2004 Paul & Daisy Soros Fellow Pavan Cheruvu has been named the CEO of Axovant Sciences, a clinical stage biopharmaceutical company. Pavan, who is the child of immigrants from India and a graduate of Harvard Medical School, was previously the chief people officer and chief of staff at Roivant Sciences.
“I am excited for the opportunity to lead Axovant, and I look forward to getting started,” said Pavan. “Our top priorities are to expand the pipeline with high-quality product candidates, solidify next steps for nelotanserin and RVT-104, and ensure operational excellence across all areas of the business. We will provide a comprehensive update on the company’s strategy by mid-year. Given Axovant’s strong cash position, we are starting from a solid foundation from which to rebuild the company’s value.”
2011 Paul & Daisy Soros Fellow Vivek Ramaswamy is the founder and CEO of Roivant Sciences, which is the umbrella organization that houses Axovant Sciences.
Learn more about the move here.
